CHRM2 and movement disorder: A variety of ADRs belonging to movement disorders (e.g., extrapyramidal disorder, Parkinsonism, and dyskinesia) were associated with several targets, including OPRK1 (9 drugs), CHRM2 (8 drugs), and ADRA1A (5 drugs).